Sanofi-Aventis To Increase S. Korea Investment By 20 Percent A Year
This article was originally published in PharmAsia News
Executive Summary
The French drug maker Sanofi-Aventis said it plans to increase its investments in South Korea by 20 percent a year to beef up its clinical research in the country. The head of Sanofi-Aventis Korea said the firm also is investigating opportunities for joint projects with South Korean companies. He said the joint efforts would be primarily in new-drug development, marketing and promotion. Sanofi-Aventis spent nearly $14 million on about 50 different clinical studies in South Korea in 2007. (Click here for more